XENE FY 2025 Earnings — Xenon Pharmaceuticals Inc. Revenue & Financial Results | Market Cap Arena

XENEXenon Pharmaceuticals Inc.

$5B

FY 2025 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$8M

Gross Profit

$5M66.1% margin

Operating Income

-$373M-4974.3% margin

Net Income

-$346M-4612.1% margin

EPS (Diluted)

$-4.36

Cash Flow

Operating Cash Flow

-$279M

Free Cash Flow

-$280M

Stock-Based Comp.

$54M

Balance Sheet

Total Assets

$633M

Total Liabilities

$51M

Stockholders' Equity

$582M

Cash & Equivalents

$199M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$8M	$0	—
Gross Profit	$5M	-$3M	+293.6%
Operating Income	-$373M	-$279M	-33.6%
Net Income	-$346M	-$234M	-47.6%